Therese Fagerqvist

Implementing precision medicine in a regionally organized healthcare system in Sweden.

Fioretos, Thoas; Wirta, Valtteri; Cavelier, Lucia; Berglund, Eva et al.

Ingår i Nature Medicine, s. 1980-1982, 2022

• DOI för Implementing precision medicine in a regionally organized healthcare system in Sweden.

Implementing precision medicine in a regionally organized healthcare system in Sweden.

Fioretos, Thoas; Wirta, Valtteri; Cavelier, Lucia; Berglund, Eva et al.

Ingår i Nature Medicine, s. 1980-1982, 2022

• DOI för Implementing precision medicine in a regionally organized healthcare system in Sweden.

Immunotherapy targeting alpha-synuclein, with relevance for future treatment of Parkinson's disease and other Lewy body disorders

Lindström, Veronica; Ihse, Elisabet; Fagerqvist, Therese; Bergström, Joakim et al.

Ingår i Immunotherapy, s. 141-153, 2014

• DOI för Immunotherapy targeting alpha-synuclein, with relevance for future treatment of Parkinson's disease and other Lewy body disorders

Immunotherapy targeting α-synuclein protofibrils reduced pathology in (Thy-1)-h[A30P] α-synuclein mice

Lindström, Veronica; Fagerqvist, Therese; Eva, Nordström; Eriksson, Fredrik et al.

Ingår i Neurobiology of Disease, s. 134-143, 2014

• DOI för Immunotherapy targeting α-synuclein protofibrils reduced pathology in (Thy-1)-h[A30P] α-synuclein mice

Off-pathway alpha-synuclein oligomers seem to alter alpha-synuclein turnover in a cell model but lack seeding capability in vivo

Fagerqvist, Therese; Näsström, Thomas; Ihse, Elisabet; Lindström, Veronica et al.

Ingår i Amyloid, s. 233-244, 2013

• DOI för Off-pathway alpha-synuclein oligomers seem to alter alpha-synuclein turnover in a cell model but lack seeding capability in vivo

Studies of α-synuclein Oligomers-with Relevance to Lewy Body Disorders

Fagerqvist, Therese

2013

• Ladda ner fulltext (pdf) av Studies of α-synuclein Oligomers-with Relevance to Lewy Body Disorders

Implementing precision medicine in a regionally organized healthcare system in Sweden.

Fioretos, Thoas; Wirta, Valtteri; Cavelier, Lucia; Berglund, Eva et al.

Ingår i Nature Medicine, s. 1980-1982, 2022

• DOI för Implementing precision medicine in a regionally organized healthcare system in Sweden.

Immunotherapy targeting α-synuclein protofibrils reduced pathology in (Thy-1)-h[A30P] α-synuclein mice

Lindström, Veronica; Fagerqvist, Therese; Eva, Nordström; Eriksson, Fredrik et al.

Ingår i Neurobiology of Disease, s. 134-143, 2014

• DOI för Immunotherapy targeting α-synuclein protofibrils reduced pathology in (Thy-1)-h[A30P] α-synuclein mice

Off-pathway alpha-synuclein oligomers seem to alter alpha-synuclein turnover in a cell model but lack seeding capability in vivo

Fagerqvist, Therese; Näsström, Thomas; Ihse, Elisabet; Lindström, Veronica et al.

Ingår i Amyloid, s. 233-244, 2013

• DOI för Off-pathway alpha-synuclein oligomers seem to alter alpha-synuclein turnover in a cell model but lack seeding capability in vivo

Monoclonal antibodies selective for α-synuclein oligomers/protofibrils recognize brain pathology in Lewy body disorders and α-synuclein transgenic mice with the disease-causing A30P mutation

Fagerqvist, Therese; Lindström, Veronica; Nordstrom, Eva; Lord, Anna et al.

Ingår i Journal of Neurochemistry, s. 131-144, 2013

• DOI för Monoclonal antibodies selective for α-synuclein oligomers/protofibrils recognize brain pathology in Lewy body disorders and α-synuclein transgenic mice with the disease-causing A30P mutation

The lipid peroxidation products 4-oxo-2-nonenal and 4-hydroxy-2-nonenal promote the formation of α-synuclein oligomers with distinct biochemical, morphological, and functional properties

Näsström, Thomas; Fagerqvist, Therese; Barbu, Mikael; Karlsson, Mikael et al.

Ingår i Free Radical Biology & Medicine, s. 428-437, 2011

• DOI för The lipid peroxidation products 4-oxo-2-nonenal and 4-hydroxy-2-nonenal promote the formation of α-synuclein oligomers with distinct biochemical, morphological, and functional properties

Immunotherapy targeting alpha-synuclein, with relevance for future treatment of Parkinson's disease and other Lewy body disorders

Lindström, Veronica; Ihse, Elisabet; Fagerqvist, Therese; Bergström, Joakim et al.

Ingår i Immunotherapy, s. 141-153, 2014

• DOI för Immunotherapy targeting alpha-synuclein, with relevance for future treatment of Parkinson's disease and other Lewy body disorders

Studies of α-synuclein Oligomers-with Relevance to Lewy Body Disorders

Fagerqvist, Therese

2013

• Ladda ner fulltext (pdf) av Studies of α-synuclein Oligomers-with Relevance to Lewy Body Disorders